NCT00467441View on ClinicalTrials.gov

VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

Not specified

Conditions
Excessive Somnolence
Interventions
DRUG

VSF-173

Trial Locations (1)

Unknown

Vanda Investigational Site, Dijon

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY

NCT00467441 - VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness | Biotech Hunter | Biotech Hunter